<DOC>
	<DOCNO>NCT02186314</DOCNO>
	<brief_summary>In study select twenty patient chronic atrial fibrillation ventricular dysfunction permanent cardiac pacemaker indication . We dosage serum level natriuretic peptide comparison conventional bifocal cardiac pacing .</brief_summary>
	<brief_title>Effect Right Bifocal Ventricular Cardiac Pacing Serum Level Natriuretic Peptides Patients With Heart Failure</brief_title>
	<detailed_description>The target study population comprise patient permanent atrial fibrillation mild moderate myocardial dysfunction accord American consensus echocardiography classical indication pacemaker Brazilian Guidelines Cardiac Implantable Electronic Devices Guidelines American Heart Association . Primary goal : Assess whether resynchronization achieve bifocal right ventricle pace influence serum level natriuretic peptide whether could use measure success . Secondary goal : To compare clinical parameter , compare electrocardiographic parameter ( QRS complex stimulate ) ventricular apical position ventricular bifocal position , assess quality life questionnaire Minnesota Living With Heart Failure . Will implant pacemaker endocardial bifocal , placement ventricular endocardial electrode septal region another right ventricle apical , adopt conduct Pacemaker sector local anesthesia sedation . After pacemaker implantation , patient randomize 1:1 ratio apical bifocal stimulation . Patients remain mode stimulation two month , subject follow sequence review : Clinical assessment ( functional classification heart failure ) ; assessment quality life Minnesota Living With Heart Failure Questionnaire , 12-lead electrocardiogram rest , measurement stimulate QRS duration , evaluation parameter pacemaker , serum level peptide . At end period evaluation , patient undergo cross-over group , apical ventricular pacing allocate bifocal group last one allocate apical ventricular pace . Patients retain new pace mode two month , end period submit clinical , laboratory assessment pacemaker evaluation well . At end study , patient keep bifocal ventricular pacing , advocate conduct Pacemaker sector .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Permanent atrial fibrillation bradycardia classic indication permanent pacemaker mild moderate ventricular dysfunction ( 35 % &lt; leave ventricle ejection fraction &lt; 55 % ) etiology Signature free inform consent Age &lt; 18 year leave ventricle ejection fraction &gt; 55 % ≤ 35 % classic indication cardiac resynchronization therapy Brazilian Guidelines Cardiac Implantable Electronic Devices Patients leave ventricle ejection fraction ≤ 35 % , permanent atrial fibrillation , heart failure functional class III IV despite optimal pharmacological treatment QRS &gt; 150 m Patients leave ventricle ejection fraction ≤ 35 % , permanent atrial fibrillation , heart failure functional class III IV despite optimal pharmacological treatment QRS 120150 m evidence dyssynchrony image method Patients indication pacemaker ventricular pace essential , leave ventricle ejection fraction ≤ 35 % heart failure functional class III IV Refusal sign informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>atrial fibrillation , heart failure , pacemaker</keyword>
</DOC>